FTC sues significant pharmacy benefit administrators more than insulin rates The agency brought motion against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record price of existence-saving insulin drugs. Sanders swiftly condemned the shift in an announcement Wednesday, noting he was dissatisfied https://andrersrrq.daneblogger.com/30031523/healthcare-news-an-overview